PHARMASGP HOLDING SE O.N.
PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
PSG
|
13/11/2024 22:59:22
|
Var.
+0.400
|
Volume |
Denaro22:59:22 |
Lettera22:59:22 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
24.200EUR
|
+1.68%
|
-
Fatturato: - |
24.200Quantità in denaro: - |
24.800Quantità in lettera: - |
292.62 mill.EUR |
5.57% |
17.81 |
Descrizione business
PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Natalie Weigand |
| Consiglio di amministrazione |
| Michael Rudolf, Peter Gerckens |
| Consiglio di sorveglianza |
| Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien |
Dati aziendali
| Name: |
PharmaSGP Holding SE |
| Indirizzo: |
Lochhamer Schlag 21,D-82166 Gräfelfing |
| Telefono: |
+49-611-2058-5528 |
| Fax: |
+49-611-2058-5566 |
| E-mail: |
info@pharmasgp.com
|
| Internet: |
https://pharmasgp.com/ |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
- |
| Data dell'IPO: |
19/06/2020 |
Rapporti con gli investitori
| Name: |
Claudius Krause |
| IR telefono: |
+49-611-2058-5535 |
| IR Fax: |
- |
| IR e-mail: |
ir@pharmasgp.com
|
Company calendar
|
CW 48 | 28/11/2024
Interim Report 3rd Quarter/9 Months
|
